The Conversation (0)
Sequenom to Receive Patent for Fetal Aneuploidy Recognition Methods
Dec. 06, 2012 03:26PM PST
Life Science Investing NewsSequenom Inc. (NASDAQ:SQNM) announced that on December 25, 2012 the US Patent and Trademark Office will issue the company US Patent No. 8,340,916 for “novel methods of detecting fetal aneuploidy using massive parallel sequencing.”
Sequenom Inc. (NASDAQ:SQNM) announced that on December 25, 2012 the US Patent and Trademark Office will issue the company US Patent No. 8,340,916 for “novel methods of detecting fetal aneuploidy using massive parallel sequencing.”
As quoted in the press release:
The patent is entitled Diagnosing Fetal Chromosomal Aneuploidy Using Massively Parallel Genomic Sequencing and was invented by Drs. Dennis Lo, Rossa Chiu and Alan Chan of the Chinese University of Hong Kong. Sequenom has exclusive rights to this patent.
Click here to read the full Sequenom Inc. (NASDAQ:SQNM) press release.